Publisher
Springer Science and Business Media LLC
Reference15 articles.
1. Spitzer AL, Lao OB, Dick AA, Bakthavatsalam R, Halldorson JB, Yeh MM, et al. The biopsied donor liver: incorporating macrosteatosis into high-risk donor assessment. Liver Transpl. 2010;16:874–984
2. Briceno J, Padillo J, Rufian S, Solorzano G, Pera C. Assignment of steatotic livers by the mayo model for end-stage liver disease. Transpl Int. 2005;18:577–583
3. Yoon YI, Lee SG, Hwang S, Kim KH, Ahn CS, Moon DB, et al. Safety of right liver donation after improving steatosis through weight loss in living donors: a retrospective study. Liver Int in press
4. Nakamuta M, Morizono S, Soejima Y, Yoshizumi T, Aishima S, Takasugi S, et al. Short-term intensive treatment for donors with hepatic steatosis in living-donor liver transplantation. Transplantation. 2005;80:608–612
5. Oshita A, Tashiro H, Amano H, Kobayashi T, Onoe T, Ide K, et al. Safety and feasibility of diet-treated donors with steatotic livers at the initial consultation for living-donor liver transplantation. Transplantation. 2012;93:1024–1030